{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:24:28Z","timestamp":1783059868714,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008837","name":"Shanghai Chest Hospital","doi-asserted-by":"publisher","award":["IS23093"],"award-info":[{"award-number":["IS23093"]}],"id":[{"id":"10.13039\/501100008837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2022KT01"],"award-info":[{"award-number":["2022KT01"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2018KT81"],"award-info":[{"award-number":["2018KT81"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103497"],"award-info":[{"award-number":["82103497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lungcan.2026.109417","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:22Z","timestamp":1776899002000},"page":"109417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4980-2462","authenticated-orcid":false,"given":"Panpan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-7854","authenticated-orcid":false,"given":"Yanbin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengping","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieran","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-3686","authenticated-orcid":false,"given":"Jian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2026.109417_b0005","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109417_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2021.06.001","article-title":"Recent updates in thoracic SMARCA4-deficient undifferentiated tumor","volume":"38","author":"Nambirajan","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109417_b0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109417_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1601443","article-title":"Updating the genomic and clinicopathologic features of thoracic SMARCA4-deficient undifferentiated tumor: a mini-series including a long-term survivor","volume":"15","author":"Ofori","year":"2025","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109417_b0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2024.03.012","article-title":"ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis","volume":"42","author":"Barisic","year":"2024","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.lungcan.2026.109417_b0030","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109417_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108022","article-title":"Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer","volume":"198","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109417_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216022","article-title":"SMARCA4: current status and future perspectives in non-small-cell lung cancer","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109417_b0045","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1007\/s00432-023-04806-y","article-title":"Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor","volume":"149","author":"Lin","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109417_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012288","article-title":"Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations","volume":"13","author":"Paredes","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lungcan.2026.109417_b0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.08.011","article-title":"STK11\/LKB1 and KEAP1 mutations in non-small cell lung cancer: prognostic rather than predictive?","volume":"157","author":"Di Federico","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109417_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063237","article-title":"Treatment of thoracic SMARCA4-deficient undifferentiated tumors: where we are and where we will go","volume":"25","author":"Longo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109417_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf266","article-title":"Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis","volume":"30","author":"Liu","year":"2025","journal-title":"Oncologist"},{"issue":"13","key":"10.1016\/j.lungcan.2026.109417_b0070","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.lungcan.2026.109417_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2022.05.001","article-title":"SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils","volume":"169","author":"Velut","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109417_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108498","article-title":"Efficacy of antiangiogenic therapy in patients with advanced SMARCA4-deficient thoracic tumor","volume":"202","author":"Shi","year":"2025","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109417_b0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/oncolo\/oyac040","article-title":"Immune-desert tumor microenvironment in thoracic SMARCA4-deficient undifferentiated tumors with limited efficacy of immune checkpoint inhibitors","volume":"27","author":"Gantzer","year":"2022","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109417_b0090","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtho.2023.01.091","article-title":"Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC","volume":"18","author":"Alessi","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109417_b0095","article-title":"Neoadjuvant immunochemotherapy in resectable NSCLC with SMARCA4 alterations","author":"Peng","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109417_b0100","article-title":"Brief report: clinical characteristics and outcomes of patients with thoracic SMARCA4-deficient undifferentiated tumors","volume":"6","author":"Cooper","year":"2025","journal-title":"JTO Clin. Res. Rep."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109417_b0105","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1007\/s00432-022-04359-6","article-title":"Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors","volume":"149","author":"Luo","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109417_b0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41417-024-00732-4","article-title":"The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation","volume":"31","author":"Li","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lungcan.2026.109417_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107818","article-title":"Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods","volume":"192","author":"Shi","year":"2024","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2026.109417_b0120","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.21037\/tlcr-2025-556","article-title":"Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study","volume":"14","author":"Liu","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109417_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108817","article-title":"The immune desert tumor microenvironment in Thoracic SMARCA4-deficient undifferentiated tumors: spatial distribution characteristics and prognostic significance","volume":"210","author":"Wang","year":"2025","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109417_b0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2024.01.008","article-title":"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion","volume":"187","author":"Leuzzi","year":"2024","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109417_b0135","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.21037\/tlcr-2025-305","article-title":"STK11\/KEAP1 co-mutations in SMARCA4-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacy","volume":"14","author":"Dong","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109417_b0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jtho.2025.03.031","article-title":"Gene copy deletion of STK11, KEAP1, and SMARCA4: biomarker for \u201ccold\u201d tumor?","volume":"20","author":"Andarini","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109417_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.762598","article-title":"A pan-cancer analysis of SMARCA4 alterations in human cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109417_b0150","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-24-2054","article-title":"Mutation of SMARCA4 induces cancer cell-intrinsic defects in the enhancer landscape and resistance to immunotherapy","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109417_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.902353","article-title":"Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma","volume":"12","author":"Shu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109417_b0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41698-021-00197-w","article-title":"Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients","volume":"5","author":"Boucher","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.lungcan.2026.109417_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616837","article-title":"Direct and indirect modulation of T cells by VEGF-a counteracted by anti-angiogenic treatment","volume":"12","author":"Bourhis","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109417_b0170","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/imt-2021-0196","article-title":"Combined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8(+) T cells in lung cancer","volume":"14","author":"Liu","year":"2022","journal-title":"Immunotherapy"},{"key":"10.1016\/j.lungcan.2026.109417_b0175","doi-asserted-by":"crossref","first-page":"16025","DOI":"10.1038\/cddiscovery.2016.25","article-title":"Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients","volume":"2","author":"Martino","year":"2016","journal-title":"Cell Death Discov."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109417_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/crj.70036","article-title":"Rapid response to penpulimab combined with anlotinib and chemotherapy in a thoracic SMARCA4-UT without PD-L1 expression: a case report and review of literature","volume":"18","author":"Wang","year":"2024","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.lungcan.2026.109417_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1453895","article-title":"Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features","volume":"14","author":"Duan","year":"2024","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109417_b0190","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00432-025-06284-w","article-title":"Long-term survival of a SMARCA4-deficient undifferentiated thoracic tumor with brain metastasis successfully treated with multimodal treatment: a case report and literature review","volume":"151","author":"Gan","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109417_b0195","article-title":"First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literature","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:56:51Z","timestamp":1783058211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226004782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S0169500226004782"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109417","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109417"}}